LLS/Chemovaccination Compound Screening (provisional title)

The University of Texas at San Antonio

The University of Texas at San Antonio is an emerging Tier One research institution with nearly 29,000 students.

Principal Investigator(s)

Hanson Kirsten

Funded by

Medicines for Malaria Venture

Research Start Date

01/01/2022

Status

Inactive

Basic Research

Collaborative Project

Basic Research

Infectious Disease

Bioscience Research Panel